z-logo
open-access-imgOpen Access
Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa
Author(s) -
Thilo Köhler,
Menno Kok,
M. Michéa-Hamzehpour,
Patrick Plésiat,
Naomasa Gotoh,
T Nishino,
Lasta Kocjancic Curty,
J C Pechère
Publication year - 1996
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.40.10.2288
Subject(s) - efflux , pseudomonas aeruginosa , microbiology and biotechnology , mutant , biology , sulfamethoxazole , multiple drug resistance , trimethoprim , pseudomonadales , pseudomonadaceae , antibiotics , wild type , bacteria , gene , genetics
Pseudomonas aeruginosa possesses at least two multiple drug efflux systems which are defined by the outer membrane proteins OprM and OprJ. We have found that mutants overexpressing OprM were two- and eightfold more resistant than their wild-type parent to sulfamethoxazole (SMX) and trimethoprim (TMP), respectively. For OprJ-overproducing strains, MICs of TMP increased fourfold but those of SMX were unchanged. Strains overexpressing OprM, but not those overexpressing OprJ, became hypersusceptible to TMP and SMX when oprM was inactivated. The wild-type antibiotic profile could be restored in an oprM mutant by transcomplementation with the cloned oprM gene. These results demonstrate that the mexABoprM multidrug efflux system is mainly responsible for the intrinsic resistance of P. aeruginosa to TMP and SMX.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom